hrcak mascot   Srce   HID

Croatian Journal of Infection, Vol. 31 No. 1, 2011

Review article

Macrolides – more than antibiotics

Vesna Eraković Haber ; Galapagos istraživački centar d.o.o. Zagreb

Fulltext: croatian, pdf (181 KB) pages 29-39 downloads: 1.137* cite
APA 6th Edition
Eraković Haber, V. (2011). Makrolidi – više od antibiotika. Infektološki glasnik, 31 (1), 29-39. Retrieved from
MLA 8th Edition
Eraković Haber, Vesna. "Makrolidi – više od antibiotika." Infektološki glasnik, vol. 31, no. 1, 2011, pp. 29-39. Accessed 22 Mar. 2019.
Chicago 17th Edition
Eraković Haber, Vesna. "Makrolidi – više od antibiotika." Infektološki glasnik 31, no. 1 (2011): 29-39.
Eraković Haber, V. (2011). 'Makrolidi – više od antibiotika', Infektološki glasnik, 31(1), pp. 29-39. Available at: (Accessed 22 March 2019)
Eraković Haber V. Makrolidi – više od antibiotika. Infektološki glasnik [Internet]. 2011 [cited 2019 March 22];31(1):29-39. Available from:
V. Eraković Haber, "Makrolidi – više od antibiotika", Infektološki glasnik, vol.31, no. 1, pp. 29-39, 2011. [Online]. Available: [Accessed: 22 March 2019]

Macrolide antibiotics play an important role in the treatment of infectious diseases because of their relatively broad antimicrobial spectrum and good safety profile. A wide usage of macrolides has lead to certain clinical observations which cannot be explained by direct antibiotic action. There are numerous reports on macrolide effect in chronic inflammatory diseases, such as diffuse panbronchiolitis, cystic fibrosis, bronchiolitis obliterans syndrome, etc. Intensive preclinical and clinical research have shown that macrolides exhibit immunomodulatory activity and that macrolide-induced inhibition of Pseudomonas aeruginosa virulence factor production and biofilm formation is responsible for some of the effects. Beneficial results of the immunomodulation, increased survival rate and decreased hospital stay, have been reported for community acquired pneumonia and sepsis. It is up to clinicians to recognise further opportunities to exploit macrolide immunomodulation, whereas drug-discovery research efforts, based on reverse pharmacology approach, should be directed towards discovery of new immunomodulatory macrolides lacking antimicrobial activity.

macrolides; immunomodulation; inflammation

Hrčak ID: 66761



Visits: 4.168 *